Latest National Heart, Lung, and Blood Institute Stories
A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment.
Ogilvy Washington Wins Fourth Successive Contract as Agency Approaches 10th Year Supporting Women's Heart Health Campaign and its Red Dress Brand WASHINGTON, Aug.
NEW YORK, Aug.
Eighty-four percent of parents say they don't know about opportunities for their children to participate in medical research; only 5 percent of children have participated in medical research across the United States ANN ARBOR, Mich., July 25, 2011 /PRNewswire-USNewswire/ -- One in nine adults have participated in medical research.
ATLANTA, July 22, 2011 /PRNewswire-USNewswire/ -- The National Forum for Heart Disease and Stroke Prevention has offered to serve as the accountability partner to ensure that surveillance recommendations laid out in the Institute of Medicine's (IOM) report A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases, which was released to the public today, are implemented. The recommendations, which the IOM released in this report sponsored by the Centers for Disease...
MADISON, Wis., July 5, 2011 /PRNewswire/ -- The Medical College of Wisconsin (MCW) and Cellular Dynamics International (CDI) today announced receipt of a research grant award from the National Heart, Lung, and Blood Institute (NHLBI) to investigate the mechanisms underlying Left Ventricular Hypertrophy.
US government researchers said on Thursday that giving a high dose of niacin to people with heart disease who are already taking a cholesterol-lowering statin does nothing more to prevent heart attacks and strokes.
Fellow to work with renowned researcher Dr.
MILFORD, Mass., May 2, 2011 /PRNewswire/ -- SeraCare Life Sciences announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011.
Scientists funded by the National Institutes of Health have identified a common genetic variant associated with substantially increased risk of developing pulmonary fibrosis, a debilitating and life-threatening lung condition.
- totally perplexed and mixed up.